ORIGINAL RESEARCH
Published on 30 May 2025
D-cycloserine effects on COPD and depression in a murine experimental model
doi 10.3389/fphar.2025.1554337
- 152 views
- Frontiers in Pharmacology
- Respiratory Pharmacology
- Research Topics
- Acute and Chronic Lung Injury: Therapeutic Targets and Drugs
Acute and Chronic Lung Injury: Therapeutic Targets and Drugs
1,178
Total downloads
7,146
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Accepted on 23 May 2025
Oxidative Stress in ARDS: Mechanisms and Therapeutic Potential
doi 10.3389/fphar.2025.1603287
- 114 views
ORIGINAL RESEARCH
Published on 20 May 2025
Longitudinal relationships between serum ferritin and prognosis among severe community-acquired pneumonia patients
doi 10.3389/fphar.2025.1556185
- 328 views
ORIGINAL RESEARCH
Published on 12 May 2025
Triglyceride-glucose index as an independent predictor of mortality in patients with chronic respiratory diseases
doi 10.3389/fphar.2025.1474265
- 558 views
ORIGINAL RESEARCH
Published on 02 May 2025
Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
doi 10.3389/fphar.2025.1506518
- 905 views
ORIGINAL RESEARCH
Published on 03 Apr 2025
Spiraea prunifolia var. simpliciflora leaves ameliorate inflammatory responses and oxidative stress in PPE/LPS-induced chronic obstructive pulmonary disease mouse model
doi 10.3389/fphar.2025.1501731
- 1,143 views
ORIGINAL RESEARCH
Published on 08 Jan 2025
Unphysiological lung strain promotes ventilation-induced lung injury via activation of the PECAM-1/Src/STAT3 signaling pathway
doi 10.3389/fphar.2024.1469783
- 749 views
ORIGINAL RESEARCH
Published on 17 Dec 2024
Mitigating inflammation and fibrosis: the therapeutic potential of quercetin liposomes in COPD
doi 10.3389/fphar.2024.1503283
- 1,235 views
- 1 citation
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.